Back to Search
Start Over
Predictive and modifying factors of bone mineral density decline in patients with COPD.
- Source :
-
Respiratory medicine [Respir Med] 2019 Mar; Vol. 148, pp. 13-23. Date of Electronic Publication: 2019 Jan 17. - Publication Year :
- 2019
-
Abstract
- Rationale: Various determinants of osteoporosis have been previously identified. However, only a few longitudinal studies have examined related factors. We aimed to investigate factors predicting and modifying rapid decline of bone mineral density in patients with chronic obstructive pulmonary disease.<br />Methods: We analyzed patients with chronic obstructive pulmonary disease whose bone mineral density were measured at least three times over three years (n = 111). We divided annual per cent changes of bone mineral density in different body parts into tertiles. Rapid decliners (n = 33) were defined as those with the largest decline in at least two parts; all other participants were defined as non-rapid decliners (n = 78).<br />Results: At enrollment, bone mineral density did not differ between the two groups. However, rapid decliners had a significantly greater rate of new vertebral fractures over 3 years compared with non-rapid decliners. On multivariate logistic regression analysis, age, moderate to severe emphysema, no daily exercise habits, and anemia increased the likelihood of rapid decliners. Furthermore, patients who newly started and continued bisphosphonate exhibited higher annual per cent changes of bone mineral density than did those without bisphosphonate use.<br />Conclusions: A rapid decline in bone mineral density correlates to a higher likelihood of vertebral fracture. We clarified the predictors of bone mineral density decline and demonstrated that bisphosphonate use might modify bone mineral density in patients with chronic obstructive pulmonary disease.<br /> (Copyright © 2019 Elsevier Ltd. All rights reserved.)
- Subjects :
- Aged
Aged, 80 and over
Bone Density physiology
Bone Density Conservation Agents administration & dosage
Bone Density Conservation Agents adverse effects
Bone Density Conservation Agents therapeutic use
Comorbidity
Female
Humans
Longitudinal Studies
Male
Osteoporosis drug therapy
Osteoporosis etiology
Predictive Value of Tests
Prevalence
Prospective Studies
Pulmonary Disease, Chronic Obstructive epidemiology
Pulmonary Disease, Chronic Obstructive physiopathology
Pulmonary Emphysema epidemiology
Risedronic Acid administration & dosage
Risedronic Acid adverse effects
Risedronic Acid therapeutic use
Spinal Fractures epidemiology
Bone Density drug effects
Osteoporosis diagnostic imaging
Pulmonary Disease, Chronic Obstructive complications
Pulmonary Emphysema diagnostic imaging
Spinal Fractures diagnostic imaging
Subjects
Details
- Language :
- English
- ISSN :
- 1532-3064
- Volume :
- 148
- Database :
- MEDLINE
- Journal :
- Respiratory medicine
- Publication Type :
- Academic Journal
- Accession number :
- 30827469
- Full Text :
- https://doi.org/10.1016/j.rmed.2019.01.005